A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers
Status:
Terminated
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This is a phase II study that will investigate weekly dosing of docetaxel in combination with
capecitabine in advanced gastric and gastro-esophageal adenocarcinomas.